COGT
Price
$4.65
Change
-$0.68 (-12.76%)
Updated
Apr 4, 02:32 PM (EDT)
Capitalization
607.39M
39 days until earnings call
DNTH
Price
$15.69
Change
-$1.28 (-7.54%)
Updated
Apr 4, 02:32 PM (EDT)
Capitalization
545.16M
Ad is loading...

COGT vs DNTH

Header iconCOGT vs DNTH Comparison
Open Charts COGT vs DNTHBanner chart's image
Cogent Biosciences
Price$4.65
Change-$0.68 (-12.76%)
Volume$2.4K
Capitalization607.39M
Dianthus Therapeutics
Price$15.69
Change-$1.28 (-7.54%)
Volume$720
Capitalization545.16M
COGT vs DNTH Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. DNTH commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Buy and DNTH is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (COGT: $5.33 vs. DNTH: $16.97)
Brand notoriety: COGT and DNTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 87% vs. DNTH: 158%
Market capitalization -- COGT: $607.39M vs. DNTH: $545.16M
COGT [@Biotechnology] is valued at $607.39M. DNTH’s [@Biotechnology] market capitalization is $545.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileDNTH’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • DNTH’s FA Score: 0 green, 5 red.
According to our system of comparison, DNTH is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while DNTH’s TA Score has 4 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 4 bearish.
  • DNTH’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, COGT is a better buy in the short-term than DNTH.

Price Growth

COGT (@Biotechnology) experienced а -19.36% price change this week, while DNTH (@Biotechnology) price change was -14.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.29%. For the same industry, the average monthly price growth was -17.13%, and the average quarterly price growth was -18.92%.

Reported Earning Dates

COGT is expected to report earnings on May 13, 2025.

DNTH is expected to report earnings on Nov 09, 2023.

Industries' Descriptions

@Biotechnology (-11.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($607M) has a higher market cap than DNTH($545M). DNTH YTD gains are higher at: -22.156 vs. COGT (-31.667). DNTH has higher annual earnings (EBITDA): -101.45M vs. COGT (-271.59M). COGT (287M) and DNTH (275M) have equal amount of cash in the bank . DNTH has less debt than COGT: DNTH (1.49M) vs COGT (17.5M). DNTH has higher revenues than COGT: DNTH (6.24M) vs COGT (0).
COGTDNTHCOGT / DNTH
Capitalization607M545M111%
EBITDA-271.59M-101.45M268%
Gain YTD-31.667-22.156143%
P/E RatioN/A3.24-
Revenue06.24M-
Total Cash287M275M104%
Total Debt17.5M1.49M1,174%
FUNDAMENTALS RATINGS
COGT vs DNTH: Fundamental Ratings
COGT
DNTH
OUTLOOK RATING
1..100
5281
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
54
Fair valued
PROFIT vs RISK RATING
1..100
7160
SMR RATING
1..100
9996
PRICE GROWTH RATING
1..100
8885
P/E GROWTH RATING
1..100
10057
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DNTH's Valuation (54) in the null industry is in the same range as COGT (81) in the Miscellaneous industry. This means that DNTH’s stock grew similarly to COGT’s over the last 12 months.

DNTH's Profit vs Risk Rating (60) in the null industry is in the same range as COGT (71) in the Miscellaneous industry. This means that DNTH’s stock grew similarly to COGT’s over the last 12 months.

DNTH's SMR Rating (96) in the null industry is in the same range as COGT (99) in the Miscellaneous industry. This means that DNTH’s stock grew similarly to COGT’s over the last 12 months.

DNTH's Price Growth Rating (85) in the null industry is in the same range as COGT (88) in the Miscellaneous industry. This means that DNTH’s stock grew similarly to COGT’s over the last 12 months.

DNTH's P/E Growth Rating (57) in the null industry is somewhat better than the same rating for COGT (100) in the Miscellaneous industry. This means that DNTH’s stock grew somewhat faster than COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTDNTH
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 24 days ago
84%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIORX37.29N/A
N/A
Victory Pioneer R
FSCDX25.78N/A
N/A
Fidelity Advisor Small Cap A
OASVX12.54N/A
N/A
Optimum Small-Mid Cap Value A
TANDX37.81N/A
N/A
Castle Tandem Institutional
MAMVX16.76N/A
N/A
MoA Mid Cap Value Fund

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-6.82%
SPHDF - COGT
63%
Loosely correlated
N/A
ENGN - COGT
47%
Loosely correlated
+1.35%
ARWR - COGT
46%
Loosely correlated
-4.96%
IDYA - COGT
44%
Loosely correlated
-4.77%
ETNB - COGT
44%
Loosely correlated
-4.59%
More

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with IMVT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
-4.98%
IMVT - DNTH
43%
Loosely correlated
-3.90%
IMNM - DNTH
42%
Loosely correlated
-7.00%
LRMR - DNTH
41%
Loosely correlated
-10.00%
COGT - DNTH
41%
Loosely correlated
-6.82%
PRME - DNTH
41%
Loosely correlated
-10.06%
More